Treatment of severe autoimmune disease by stem-cell transplantation (Q36148421)

12 August 2017

1 reference

title

Treatment of severe autoimmune disease by stem-cell transplantation (English)

1 reference

stem cell transplantation

12 August 2017

1 reference

1 reference

Megan Sykes

1

1 reference

12 August 2017

Boris Nikolic

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

435

1 reference

12 August 2017

7042

1 reference

12 August 2017

620-627

1 reference

https://scigraph.springernature.com/pub.10.1038/nature03728

12 August 2017

0 references

cites work

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Treatment of type 1 diabetes mellitus in non-obese diabetic mice by transplantation of allogeneic bone marrow and pancreatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Combined short-term immunotherapy for experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Experimental basis for the treatment of autoimmune diseases with autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

High-dose cyclophosphamide for aplastic anemia and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

The promise of hematopoietic stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Allogeneic stem cell transplantation for Evans syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

A novel strategy for allogeneic stem cell transplantation: perfusion method plus intra-bone marrow injection of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Mixed chimerism and transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

A mechanism for the major histocompatibility complex-linked resistance to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Prevention of type 1 diabetes by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Tolerance in mixed chimerism - a role for regulatory cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Regulatory CD4+ T cells and the control of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Treatment of severe Evans syndrome with an allogeneic cord blood transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Embryonic stem cells as an alternate marrow donor source: engraftment without graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Bone marrow-derived stem cells initiate pancreatic regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Changing potency by spontaneous fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Recruitment of Bone Marrow-Derived Endothelial Cells to Sites of Pancreatic -Cell Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

Bone marrow transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

A new look at MHC and autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

In a Transgenic Model of Spontaneous Autoimmune Diabetes, Expression of a Protective Class II MHC Molecule Results in Thymic Deletion of Diabetogenic CD8+ T Cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Origin of regulatory T cells with known specificity for antigen

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Induction of human T-cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03728

7 January 2021

Identifiers

DOI

10.1038/NATURE03728

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference